Objective: To study the β-glucosidase gene (bgy1) from Lactobacillus brevis that was cloned and expressed in Escherichia coli BL21 (DE3) and then using it for the biotransformation of gypenoside XVII.
Results: The bgy1 gene consists of 2283 bp encoding 761 amino acids, with homology to the glycosyl hydrolase family-3 protein domain. The enzyme (Bgy1) hydrolyzed the glucose moieties at the C-3 position and the outer glucose moieties at the C-20 position of gypenoside XVII. Using 0.1 mg enzyme ml(-1) in 20 mM sodium phosphate buffer at 30 °C and pH 6.0, 1 mg gypenoside XVII ml(-1) was transformed into 0.58 mg compound K ml(-1) within 6 h, with a corresponding molar conversion yield of 89 %.
Conclusion: The recombinant Bgy1 is considered potentially useful for the practical preparation of compound K.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10529-016-2094-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Screening and verification of target and molecular docking study of Pien-Tze-Huang in ameliorating alcoholic liver injury in rats.
J Pharm Biomed Anal
January 2025
School of Pharmacy, Fujian Medical University, Fuzhou, Fujian 350122, China. Electronic address:
Pien-Tze-Huang (PTH) is a famous traditional Chinese patent medicine with excellent liver-protection effects. However, the mechanism of hepatoprotective action has not yet been entirely elucidated. This study aimed to elucidate the protective mechanism of PTH against alcoholic liver injury in rats from key targets.
View Article and Find Full Text PDFVariation in ginsenoside content and composition within the American ginseng population.
Nat Prod Res
October 2024
Institute of Special Animal and Plant, Chinese Academy of Agricultural Sciences, Changchun, China.
Article Synopsis
- A study measured 57 types of ginsenosides in American ginseng roots from a single population in Jilin, revealing significant variations in their content and composition.
- The most common ginsenosides found were either Rg or Re, and the population was categorized into two chemotypes based on their relative amounts.
- The research also indicated stable levels of protopanaxadiol-type ginsenosides and identified key enzymes and regulatory sites involved in the biosynthesis of different ginsenoside types.
Cloning, characterization of β-glucosidase from Furfurilactobacillus rossiae in bioconversion and its efficacy.
Arch Microbiol
October 2024
Hanbangbio Inc, Yongin-si, Gyeonggi-do, 17104, Republic of Korea.
Article Synopsis
- Minor ginsenosides produced by β-glucosidase have significant biological and pharmaceutical potential, leading to the cloning and expression of a ginsenoside-hydrolyzing enzyme from Furfurilactobacillus rossiae DCYL3 in E. coli.
- The enzyme successfully converted ginsenosides Rb1 and Gyp XVII into Rd and compound K under optimal conditions, demonstrating its effectiveness in bioconversion.
- The bioconverted Gynostemma extract (BGE) showed increased cytotoxicity against lung cancer cells compared to the non-converted extract, while also reducing inflammation through the downregulation of pro-inflammatory genes in macrophage cells.
Natural compounds from herbs and nutraceuticals as glycogen synthase kinase-3β inhibitors in Alzheimer's disease treatment.
CNS Neurosci Ther
August 2024
Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Background: Alzheimer's disease (AD) pathogenesis is complex. The pathophysiology is not fully understood, and safe and effective treatments are needed. Glycogen synthase kinase 3β (GSK-3β) mediates AD progression through several signaling pathways.
View Article and Find Full Text PDFGypenoside XVII Reduces Synaptic Glutamate Release and Protects against Excitotoxic Injury in Rats.
Biomolecules
May 2024
School of Medicine, Fu Jen Catholic University, New Taipei 24205, Taiwan.
Excitotoxicity is a common pathological process in neurological diseases caused by excess glutamate. The purpose of this study was to evaluate the effect of gypenoside XVII (GP-17), a gypenoside monomer, on the glutamatergic system. In vitro, in rat cortical nerve terminals (synaptosomes), GP-17 dose-dependently decreased glutamate release with an IC value of 16 μM.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!